Pharmesis International Ltd. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenue of RMB 13,434,000 compared to RMB 15,168,000 a year ago. Loss from operations was RMB 1,777,000 compared to RMB 1,146,000 a year ago.

Loss before tax was RMB 1,126,000 compared to RMB 1,124,000 a year ago. Loss attributable to equity holders of the company was RMB 459,000 or 0.23 per diluted share compared to RMB 1,005,000 or 0.50 per diluted share a year ago. Net cash flows from operating activities were RMB 872,000 compared to RMB 1,627,000 a year ago.

Acquisition of property, plant and equipment and construction in progress was RMB 83,000 compared to RMB 110,000 a year ago.